Help us: Donate
Follow us on:
×

Tag: Investment

Investment
2021 marked one of the biggest years in longevity financing, with 2022 following closely behind, according to a report by Longevity.Technology. Over the past ten years, the industry has grown in financing from $500 million in 2013 to a peak of $6.2 billion (2021). Despite taking a dip in 2022, investment in longevity appears to...
Worldwide finance
  With news of H.E. Justin Sun’s plans to invest $51K into the Longevity Prize, a fund seeking to stimulate innovative research proposals, it appears that there is a marked interest within the crypto and tech communities in longevity science. Sun’s donation comes after Vitalik Buterin’s contribution of $130K and Stefan George’s $6.5K to the...
Coinbase logo
Coinbase CEO, Brian Armstrong, has announced his intention to sell 2% of his Coinbase stock and invest the funds into innovative longevity research in a move that could see ~$54 million put towards the advancement of longevity science. Visit the VitaDAO website to learn how you can get involved. Armstrong’s decision echoes that of other...
Investment decision
Marking one of VitaDAO’s largest investments to date, the decentralized organization has allocated $1,000,000 in funding to Turn.Bio. This company, also known as Turn Biotechnologies, plans to undertake preclinical efficacy testing of mRNA therapeutics intended to induce self-healing of the skin and eyes. Through this purchase of an equity stake, VitaDAO is investing into the...
Optimistic outlook
Two investors, including a co-founder of Coinbase, have announced a new biotech venture that aims to solve aging by studying its epigenetic aspects. New kid on the block Long gone are the times when longevity biotech companies were scarce and poorly funded. Today, barely a week goes by without a major launch announcement, and more...
Apollo logo
Apollo Health Ventures, a venture capitalist firm focusing on rejuvenation biotechnology, has raised $180 million in order to fund companies developing interventions that target age-related diseases. We have included the full press release below. Apollo Health Ventures Closes $180 Million Fund to Drive Breakthrough Innovations Combating Age-related Diseases BOSTON and BERLIN, December 1, 2021 –...